Apollomics files Form 3 as director Yen Hung Hsien reports beneficial ownership
Apollomics appoints Hung-Hsien Yen to board after two directors resign
12 Health Care Stocks Moving In Friday's Intraday Session
Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch
Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Data
Apollomics regains Nasdaq compliance with $35 million market value requirement